These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1000 related articles for article (PubMed ID: 26810565)

  • 1. Incidence of chronic heart failure with preserved left ventricular ejection fraction in patients with hypertension and isolated mild diastolic dysfunction.
    Brzyżkiewicz H; Konduracka E; Gajos G; Janion M
    Pol Arch Med Wewn; 2016; 126(1-2):12-8. PubMed ID: 26810565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acutely decompensated heart failure with preserved and reduced ejection fraction present with comparable haemodynamic congestion.
    Van Aelst LNL; Arrigo M; Placido R; Akiyama E; Girerd N; Zannad F; Manivet P; Rossignol P; Badoz M; Sadoune M; Launay JM; Gayat E; Lam CSP; Cohen-Solal A; Mebazaa A; Seronde MF
    Eur J Heart Fail; 2018 Apr; 20(4):738-747. PubMed ID: 29251818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Predictors of Heart Failure With Preserved Versus Reduced Ejection Fraction in a Multiracial Cohort of Preclinical Left Ventricular Diastolic Dysfunction.
    Zhang L; Liebelt JJ; Madan N; Shan J; Taub CC
    Am J Cardiol; 2017 Jun; 119(11):1815-1820. PubMed ID: 28450040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional iron deficiency and diastolic function in heart failure with preserved ejection fraction.
    Kasner M; Aleksandrov AS; Westermann D; Lassner D; Gross M; von Haehling S; Anker SD; Schultheiss HP; Tschöpe C
    Int J Cardiol; 2013 Oct; 168(5):4652-7. PubMed ID: 23968714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular features of heart failure with preserved ejection fraction versus nonfailing hypertensive left ventricular hypertrophy in the urban Baltimore community: the role of atrial remodeling/dysfunction.
    Melenovsky V; Borlaug BA; Rosen B; Hay I; Ferruci L; Morell CH; Lakatta EG; Najjar SS; Kass DA
    J Am Coll Cardiol; 2007 Jan; 49(2):198-207. PubMed ID: 17222731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of ST2 and B-type natriuretic peptide in diabetic patients with acute heart failure: relation with ventricular stiffness and outcome.
    Ruocco G; Evangelista I; Franci B; Lucani B; Martini S; Nuti R; Palazzuoli A
    J Cardiovasc Med (Hagerstown); 2019 Feb; 20(2):81-90. PubMed ID: 30540645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Prognostic Usefulness of Serum Insulin-Like Growth Factor-Binding Protein 7 in Patients With Heart Failure and Preserved Versus Reduced Left Ventricular Ejection Fraction.
    Hage C; Bjerre M; Frystyk J; Gu HF; Brismar K; Donal E; Daubert JC; Linde C; Lund LH
    Am J Cardiol; 2018 Jun; 121(12):1558-1566. PubMed ID: 29622288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered spatial distribution of the diastolic left ventricular pressure difference in heart failure.
    Iwano H; Kamimura D; Fox E; Hall M; Vlachos P; Little WC
    J Am Soc Echocardiogr; 2015 May; 28(5):597-605.e1. PubMed ID: 25691001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of B-type natriuretic peptide in hypertensive patients with exertional dyspnea and normal left ventricular ejection fraction and correlation with new echocardiographic indexes of systolic and diastolic function.
    Mottram PM; Leano R; Marwick TH
    Am J Cardiol; 2003 Dec; 92(12):1434-8. PubMed ID: 14675580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BNP and obesity in acute decompensated heart failure with preserved vs. reduced ejection fraction: The Atherosclerosis Risk in Communities Surveillance Study.
    Khalid U; Wruck LM; Quibrera PM; Bozkurt B; Nambi V; Virani SS; Jneid H; Agarwal S; Chang PP; Loehr L; Basra SS; Rosamond W; Ballantyne CM; Deswal A
    Int J Cardiol; 2017 Apr; 233():61-66. PubMed ID: 28185703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of serum triiodothyronine with B-type natriuretic peptide and severe left ventricular diastolic dysfunction in heart failure with preserved ejection fraction.
    Selvaraj S; Klein I; Danzi S; Akhter N; Bonow RO; Shah SJ
    Am J Cardiol; 2012 Jul; 110(2):234-9. PubMed ID: 22502900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Creation of a restrictive atrial communication in heart failure with preserved and mid-range ejection fraction: effective palliation of left atrial hypertension and pulmonary congestion.
    Bauer A; Khalil M; Lüdemann M; Bauer J; Esmaeili A; De-Rosa R; Voelkel NF; Akintuerk H; Schranz D
    Clin Res Cardiol; 2018 Sep; 107(9):845-857. PubMed ID: 29663123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B-Type Natriuretic Peptide in Heart Failure With Preserved Ejection Fraction　- Relevance to Age-Related Left Ventricular Modeling in Japanese.
    Harada E; Mizuno Y; Kugimiya F; Shono M; Maeda H; Yano N; Kuwahara K; Yasue H
    Circ J; 2017 Jun; 81(7):1006-1013. PubMed ID: 28381705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different implication of elevated B-type natriuretic peptide level in patients with heart failure with preserved ejection fraction and in those with reduced ejection fraction.
    Ishigaki T; Yoshida T; Izumi H; Fujisawa Y; Shimizu S; Masuda K; Asanuma T; Okabe H; Nakatani S
    Echocardiography; 2015 Apr; 32(4):623-9. PubMed ID: 25115860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arterial stiffness and elevated left ventricular filling pressure in patients at risk for the development or a previous diagnosis of HF-A subgroup analysis from the DIAST-CHF study.
    Lüers C; Trippel TD; Seeländer S; Wachter R; Hasenfuss G; Lindhorst R; Bobenko A; Nolte K; Pieske B; Edelmann F
    J Am Soc Hypertens; 2017 May; 11(5):303-313. PubMed ID: 28411073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of characteristics and outcomes of patients with heart failure preserved ejection fraction versus reduced left ventricular ejection fraction in an urban cohort.
    Quiroz R; Doros G; Shaw P; Liang CS; Gauthier DF; Sam F
    Am J Cardiol; 2014 Feb; 113(4):691-6. PubMed ID: 24484862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex Differences in Heart Failure With Preserved Ejection Fraction Reflected by B-type Natriuretic Peptide Level.
    Harada E; Mizuno Y; Kugimiya F; Shono M; Maeda H; Yano N; Yasue H
    Am J Med Sci; 2018 Oct; 356(4):335-343. PubMed ID: 30360801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparable prognostic impact of BNP levels among HFpEF, Borderline HFpEF and HFrEF: a report from the CHART-2 Study.
    Kasahara S; Sakata Y; Nochioka K; Yamauchi T; Onose T; Tsuji K; Abe R; Oikawa T; Sato M; Aoyanagi H; Miura M; Shiroto T; Takahashi J; Miyata S; Shimokawa H;
    Heart Vessels; 2018 Sep; 33(9):997-1007. PubMed ID: 29569034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Load-Independent Systolic and Diastolic Right Ventricular Function in Heart Failure With Preserved Ejection Fraction as Assessed by Resting and Handgrip Exercise Pressure-Volume Loops.
    Rommel KP; von Roeder M; Oberueck C; Latuscynski K; Besler C; Blazek S; Stiermaier T; Fengler K; Adams V; Sandri M; Linke A; Schuler G; Thiele H; Lurz P
    Circ Heart Fail; 2018 Feb; 11(2):e004121. PubMed ID: 29449367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex-related differences in left ventricular diastolic function and arterial elastance during admission in patients with heart failure with preserved ejection fraction: The PURSUIT HFpEF study.
    Hoshida S; Watanabe T; Shinoda Y; Ikeoka K; Minamisaka T; Fukuoka H; Inui H; Ueno K; Suna S; Nakatani D; Hikoso S; Yamada T; Yasumura Y; Fuji H; Sakata Y;
    Clin Cardiol; 2018 Dec; 41(12):1529-1536. PubMed ID: 30225990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 50.